MedTrace Logo

Transurethral Ventral Wall of Urethra-preserving Enucleation of Prostate

NCT01073241 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2010-03-15

No results posted yet for this study

Summary

In this study, the investigators designed a randomized and double-blind prospective trial to evaluate the efficiency and safety of the investigators new approach-transurethral ventral wall of urethra-preserving enucleation of prostate in comparison with TURP for the hyperplasia weighing more than 45 g.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

PROCEDURE

transurethral ventral wall of urethra-preserving enucleation of prostate

The patients' ventral wall of the prostate urethra was preserved and enucleation of prostate was performed for the left hyperplasia in the envelop.

PROCEDURE

transurethral prostatic resection

The patients' prostate was resected with the conventional Nesbit TURP

Sponsors & Collaborators

  • Southwest Hospital, China

    lead OTHER

Principal Investigators

  • Zhang Jiahua · Urology Institute of Southwest Hospital, Chongqin, China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
90 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • China

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01073241 on ClinicalTrials.gov